S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
Predicting a Bear Market: 7 Signs and Why it's Tough to Do

Entrada Therapeutics (TRDA) SEC Filings & 10K Form

$12.22
-0.50 (-3.93%)
(As of 04/17/2024 ET)

Recent Entrada Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2024
3:16 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:18 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/11/2024
3:23 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:35 PM
Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:14 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/09/2024
3:12 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2024
4:16 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/05/2024
3:17 PM
Entrada Therapeutics (Subject)
KREHER NERISSA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
3:31 PM
Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
4:57 PM
Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:31 PM
Entrada Therapeutics (Issuer)
KIM PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
3:33 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
6:36 AM
Entrada Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/13/2024
6:24 AM
Entrada Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
6:08 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
3:34 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:36 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:22 PM
Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:22 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:44 PM
Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:46 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:47 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:48 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:37 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
3:19 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
3:32 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
6:16 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
3:35 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:38 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2023
3:26 PM
Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
3:40 PM
Crowley John F (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2023
4:25 PM
Crowley John F (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2023
4:24 PM
Crowley John F (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/14/2023
3:38 PM
Crowley John F (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
4:14 PM
Crowley John F (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
6:00 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
6:35 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:35 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2023
6:20 AM
Entrada Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2023
6:08 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2023
6:01 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Did You Get Your Free Bitcoin Yet? (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here
10/19/2023
4:27 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/29/2023
3:35 PM
Entrada Therapeutics (Filer)
Form 424B5
09/29/2023
3:39 PM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
6:09 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2023
3:21 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:07 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:08 PM
Entrada Therapeutics (Issuer)
KREHER NERISSA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2023
4:09 PM
Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:31 PM
Chapman Gina (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
3:32 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
6:09 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:23 AM
Entrada Therapeutics (Filer)
Form 10-K/A
08/08/2023
6:25 AM
Entrada Therapeutics (Filer)
Form 10-Q/A
08/08/2023
6:07 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2023
6:14 AM
Entrada Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2023
6:08 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
3:32 PM
Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:33 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2023
3:34 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2023
3:11 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2023
3:12 PM
Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/30/2023
3:32 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2023
3:20 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:46 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2023
3:12 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/21/2023
3:18 PM
Entrada Therapeutics (Subject)
WENTWORTH KORY JAMES (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/20/2023
3:27 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/08/2023
4:11 PM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2023
6:45 AM
Entrada Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2023
6:16 AM
Entrada Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2023
3:38 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2023
6:00 AM
Entrada Therapeutics (Filer)
Form DEF 14A
04/25/2023
6:01 AM
Entrada Therapeutics (Filer)
Form DEFA14A
04/25/2023
6:03 AM
Entrada Therapeutics (Filer)
Form ARS
04/19/2023
4:50 PM
Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4/A
04/19/2023
4:52 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4/A
04/19/2023
5:06 PM
Entrada Therapeutics (Issuer)
Sethuraman Natarajan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2023
5:07 PM
Doshi Dipal (Reporting)
Entrada Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2023
4:46 PM
Dowden Nathan J (Reporting)
Entrada Therapeutics (Issuer)
Form 4/A
04/19/2023
4:48 PM
Entrada Therapeutics (Issuer)
KREHER NERISSA (Reporting)
Form 4/A
04/19/2023
4:49 PM
Entrada Therapeutics (Issuer)
WENTWORTH KORY JAMES (Reporting)
Form 4/A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TRDA) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners